SUMMARY ANSWER: miR-378a-3p expression is regulated by progesterone and is down-regulated in ducidua of EPL patients which may contribute to decidual apoptosis through Caspase-3 activation.
Introduction
Human reproduction is a complicated and inefficient process frustrating both clinicians and patients. Approximately 50-70% of early pregnancy losses (EPL) are reported to occur in the first trimester (Jauniaux and Burton, 2005) . Even after a successful implantation, clinical miscarriage occurs in~15-20% of pregnancies (Wilcox et al., 1988; Jauniaux and Burton, 2005) . The incidence of EPL is high in the first trimester, then drops rapidly after 11 weeks of gestation, when the fetal loss rate is <3% (Pandya et al., 1996) . The diagnosis of EPL is made according to urine tests for hCG and the use of transvaginal ultrasound. Although, many causes of EPL are known, such as chromosomal abnormalities, abnormal anatomy of the maternal genital tract, endocrine disorders, infections, trauma, autoimmune diseases, coagulation disorders and psychological factors, in 41-70% of cases, the etiology remains unknown (Kwak-Kim et al., 2010) . Given that the complex and variable nature of this condition, further studies are needed to explore the mechanisms of EPL (Zinaman et al., 1996; Norwitz et al., 2001; Kwak-Kim et al., 2010) .
A successful pregnancy requires two important elements, a quality embryo and maternal endometrial receptivity (Paria et al., 2002) . During periods of embryonic implantation and placental formation, the endometrium undergoes extensive cyclic biochemical and morphologic modifications. This process is referred to as the decidualization of stromal cells, and is critical for the embryo to adhere to and invade the uterine epithelium (Edwards, 1995; Paria et al., 2002; Liao et al., 2015) . Decidualization provides important nutritional support for embryo development and protects the embryo from maternal immune rejection (Mizugishi et al., 2007; Singh et al., 2011; Schwenke et al., 2013) . Decidualization is influenced by various molecular mediators, such as cytokines, chemokines, growth factors, lipids and adhesion molecules through estrogen and progesterone signaling pathways (Boomsma et al., 2010; Srivastava et al., 2013) . Yet up to now, little is known about post-transcriptional regulation in the decidual transformation of the post-implantation endometrium. Insufficient decidualization and defective placentation can lead to EPL, or later complications of gestation such as fetal growth restriction and preeclampsia (Ventura et al., 2013) .
MicroRNAs (miRNAs) are small, endogenous, non-coding RNAs composed of 17-25 nucleotides (Lee et al., 1993; Wightman et al., 1993) , which act as post-transcriptional regulators of many target genes through control of mRNA stability or translation (Fire et al., 1998; Morales-Prieto and Markert, 2011) . MiRNAs have been shown to participate in many cellular activities, such as proliferation, development, angiogenesis, differentiation, apoptosis, migration and invasion (Kotlabova et al., 2011) . A growing body of data has identified more than 500 miRNAs expressed in the human placenta (Morales- Prieto et al., 2014) . Many investigations have demonstrated that miRNAs play an important roles in embryonic development, growth and maturity (Bueno et al., 2008; Meola et al., 2009) . Some specific miRNAs are expressed in early embryonic stem cells and during embryonic development (Chao et al., 2010; Navarro and Monzo, 2010) . MiRNAs have also been associated with the development of decidualization and placental formation (Creighton et al., 2010; Evans et al., 2012; Galliano and Pellicer, 2014; Hossain et al., 2014; Wang et al., 2015) .
Despite these interesting findings, the majority of decidual miRNAs remain unknown. Moreover, the expression patterns and roles of miRNAs in the regulation of decidualization with EPL have not yet been fully elucidated (Mouillet et al., 2011) . In the present study, we used miRNA microarray analysis to determine the differential expression of miRNAs in the decidua of EPL and normal pregnant women. After verification by quantitative real-time PCR, miR-378a-3p, which was significantly down-regulated, caught our attention. Through bioinformatics algorithms and previous studies , we had found that Caspase-3, an important apoptosis-related protein, was predicted to be a putative target of miR-378a-3p. Further studies showed that transfection of miR-378a-3p mimics, by targeting Caspase-3, resulted in the inhibition of decidual cell apoptosis and in increased proliferation. We speculate that the expression of miR378a-3p together with its target gene might be an important underlying mechanism of EPL. Moreover, we observed that miR-378a-3p was positively up-regulated by progesterone, which may shed light on the underlying mechanism for progesterone-treatment of EPL.
Materials and methods

Ethics statement
This study was approved by the Ethical Review Committee of Women's Hospital, School of Medicine, Zhejiang University. Written informed consent was obtained from each participant.
Patients and samples
During the period of January 2015-June 2016, 50 pregnant women (age: 21-35 years old, 28.43 ± 4.21 (mean ± SD) with a diagnosis of EPL in Women's Hospital School of Medicine Zhejiang University, were randomly designated as the case group. Other age-matched women with normal pregnancies and undergoing elective termination of gestation formed the control group. In addition, eight progesterone-treated pregnant women with a diagnosis of EPL were selected randomly to detect the miR-378a-3p expression. All pregnant women had a gestational age of 6-8 weeks. Detailed information about the study participants is summarized in Table 1 . EPL was identified by clinical history, clinical examination and transvaginal ultrasound (gestational sac without fetal heart activity). Participants were recruited if they met the following criteria: (i) no history of recurrent spontaneous abortions; (ii) no chromosomal abnormalities; (iii) no abnormal maternal reproductive tract anatomy; (iv) normal menstruation; (v) no history of trauma; (vi) no history of autoimmune disease; (vi) no history of chronic disease or smoking and (viii) no male factors (Jauniaux and Burton, 2005) .
Decidual tissue and peripheral blood collection
After being extracted through the cervix during dilation and aspiration, decidual tissues from the patients with a gestational age of 6-8 weeks were separated immediately and incubated into TRIzol (Invitrogen, Carlsbad, CA, USA) reagent and stored at −80°C until further analysis. Before the abortion operation, 2 ml peripheral blood samples were collected into EDTA blood collection tubes (Becton-Dickinson, Sunnyvale, CA, USA) for further analysis.
Microarray analysis
Total RNA was extracted from decidual tissues using TRIzol (Invitrogen, Carlsbad, CA, USA). RNA samples from normal pregnant women (n = 3) and EPL patients (n = 3) were sent to CapitalBio Corporation (Beijing, China) for miRNA expression analysis. miRNAs were enriched from total RNA using the mirVana ® miRNA Isolation Kit (Ambion, Foster City, CA, USA) and labeled using the FlashTag™Biotin RNA Labeling Kit. Following hybridization of labeled miRNAs to miRNA microarrays (Affymetrix, Santa Clara, CA, USA), images were acquired using an Affymetrix GeneChip Scanner 3000 7 G. , and data summarization, normalization and quality control was performed using free miRNA QC Tool software. To determine the significant differentially expressed genes, Significance Analysis of Microarrays (SAM, version 3.02) was used. To select the differentially expressed genes, we used threshold values of ≥1.5 and ≤−1.5-fold change and a false discovery rate significance level of <5%. The data were Log2 transformed and median centered by genes using the adjust data function. Comparison of samples was based on the Wilcoxon Rank-Sum test. Control targets were also included in the array that contained 95 background probe sets, 22 oligonucleotide spike-in control probe sets, probes for human 5.8 s rRNA and hybridization control probe sets.
RNA isolation and quantitative real-time PCR
Total RNA from tissues and cells was isolated using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's instructions. Total RNA from whole blood was isolated using RNAiso Blood reagent (TaKaRa Biotechnology Co., Ltd., Dalian, China). cDNA was synthesized using the PrimeScript RTreagent kit (TaKaRa Biotechnology Co., Ltd., Dalian, China). Real-time quantitative PCR using SYBR Green detection chemistry (Roche Diagnostics GmbH, Penzberg, Germany) was performed on LightCycler ® 480 Instrument (Roche Diagnostics GmbH, Penzberg, Germany). For miRNA analysis, the RT and PCR primer sequences are shown in Tables 2 and 3 , respectively. The relative expression levels of miRNA were normalized to that of internal control U6, while the relative expression of genes was normalized to the level of GAPDH expression in each sample.
3′-UTR luciferase reporter assay
The wild-type human Caspase-3 3′-UTR luciferase reporter vector was constructed by amplifying the human Caspase-3 mRNA 3′-UTR and cloning it into the PGL3-promoter vector (Promega, Madison, WI, USA). HEK-293 cells were co-transfected with luciferase reporter plasmid, thymidine kinase promoter-Renilla luciferase reporter plasmid and the indicated miRNA mimics or controls (final concentration, 20 nM). After growing 24 h, the cells were collected for application in the Dual-Luciferase Reporter System (Promega, Madison, WI, USA) following the manufacturer's instructions. All the dual-luciferase reporter assays were done in triplicate for each experiment, and three independent experiments were conducted.
Cell culture and transfection
Fresh decidual tissues from 6 to 8 weeks of pregnancy were treated through Collagenase IV (0.25% w/v) digestion and centrifugation. The whole decidual cells were cultured in RPMI1640 containing 10% fetal calf serum and the cells were purified through natural proliferation. The expression of prolactin (PRL) was tested using immunofluorescence to identify the purity of the cell preparation. MiR-378a-3p dsRNA mimics or control, inhibitors or inhibitor control from GenePharma (GenePharma Co., Ltd, Shanghai, China) were used to test the over-expression or inhibition of miR-378a-3p, respectively. Decidual cells were transfected with RNAs at a final concentration of 40 nM using INTERFERin (Polyplus-transfection, Illkirch, France), according to the manufacturer's instructions. All the cells were cultured at 37°C in a humidified incubator with 5% CO 2 .
Determination of cell viability
Cell viability was determined by the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) (Sigma-Aldrich Co., St Louis, MO, USA)) assay based on published procedures (Gomez et al., 1997 
Apoptosis detection assay
Apoptosis was induced by serum starvation for 2 days, then cells were suspended in 100 μl-binding buffer (1×) including 1 μl Annexin V-FITC and 10 μl propidium iodide (PI) (eBioscience, Inc., San Diego, CA, USA) for 15 min in dark at room temperature, and then, 400 μl-binding buffer (1×) was added to each sample. The FITC and PI fluorescence was measured through a FL-1 (530 nm) and FL-2 (585 nm) filter, respectively, by the FACS Calibur (Becton-Dickinson, Franklin Lakes, NJ, USA). All the experiments were conducted at least three times.
Western blotting
The cells were washed with cold PBS and then homogenized with cell lysis buffer (Cell Signaling Technology, Danvers, MA, USA) supplemented with PMSF (Beyotime, Shanghai, China). The lysates were loaded onto sodium dodecyl sulfate poly acrylamide gels (SDS-PAGE) and transferred onto polyvinylidene difluoride (PVDF) membranes (Bio-Rad Laboratories Inc., Hercules, CA, USA). Detection of proteins was conducted using ECL reagent (Thermo Fisher, Waltham, MA, USA).
Immunohistochemistry
For immunohistochemical analysis, decidual tissues were obtained from clinically normal pregnancies and EPL patients. Tissue samples fixed in formaldehyde and embedded in paraffin were heated to 60°C and washed in xylene for de-waxing, then dehydrated through graded alcohols (100, 96, 90 and 70%) and distilled water. Slides were processed for antigen retrieval by a standard microwave heating technique. Normal non-immune fetal bovine serum and 0.5% H 2 O 2 in methanol were used to block nonspecific antibody binding and endogenous peroxidase activity, respectively. Slides were incubated with the primary antibody caspase-3 (Cell Signaling Technology, Danvers, MA, USA) overnight at 4°C. The slides were subsequently incubated with appropriate horseradish peroxidase conjugated rabbit secondary antibody for 30 min at room temperature. The signal was developed using 3,3′-diaminobenzidine (DAB) chromogen. For the TUNEL detection, tissue samples were prepared using in situ Cell Death Detection Kit (Roche Diagnostics GmbH, Penzberg, Germany) and subsequently analyzed by fluorescence microscopy. Representative images of all staining intensities were taken at random.
Statistical analysis
Data are represented as mean ± SE. The significant difference between two groups was determined by Student's t-test or the Mann-Whitney U-test using GraphPad PrismVersion 6 (San Diego, CA, USA). Multiple comparisons were assessed by one-way ANOVA with Bonferroni post ttests. The correlation between miR-378a-3p and Caspase-3 expression 
Results
Differential expression of miRNAs in decidua of EPL patients
In order to analyze the changes in expression of miRNAs in the decidua of EPL patients (3) compared to that of normal pregnant women (3), we examined the global miRNA expression profiles using miRNA microarray assays. A total of 70 miRNAs were either up-or downregulated by at least 1.5-fold in the EPL patients, including 32 upregulated miRNAs and 38 down-regulated miRNAs (Fig. 1A and B) . According to the results of the SAM (version 3.02) and bioinformatic prediction of potential target genes, we selected three up-regulated (miR-29c-3p, miR-125a-5p, miR-193a-5p) and four down-regulated (miR-378a-3p, miR-378c, miR-422a miR-378a-5p) miRNAs in EPL decidua (Fig. 1C) to be verified by real-time PCR. Based on the results of RT-PCR, the expression of all three up-regulated miRNAs was confirmed to be increase in EPL decidua. Three out of the four downregulated miRNAs were also confirmed to have lower expression levels by RT-PCR (all except for miR-422a). Thus, the PCR results were mostly in accordance with the microarray data. Of interest, miR-378a-3p, miR-378c and miR-422a contain the same seed sequences and belong to the miR-378a family. Thus, they may regulate their target genes synergistically. MiR-378a-3p, one of the most abundant miRNA in decidua was down-regulated more significant than other miRNAs in EPL, and was selected for further functional studies (Fig. 1D) . The expression of miR-378a-3p in the blood of EPL and normal pregnant Expression profile of differential miRNAs in the blood of EPL patients (n = 15) and normal (n = 17), quantified by qRT-PCR, and normalized to the expression of U6. Data are presented as mean ± SEM. The significant difference between two groups was determined by Mann-Whitney U-test. *P < 0.05 and **P < 0.01.
women was measured by qRT-PCR. The result indicates that the expression of miR-378a-3p in EPL blood is also significantly lower than in normal blood (0.9268 ± 0.0887 vs 1.412 ± 0.1210), suggesting that miR-378a-3p may be a predictive marker for EPL (Fig. 1E ).
MiR-378a-3p enhances cell viability and reduces apoptosis in decidual cells
To assess whether miR-378a-3p plays a major role in regulating the function of decidual cells, we cultured primary human decidual cells in vitro for further investigation. The PRL immunofluorescence results showed the purity of the cell preparation was more than 90%, suggesting that the culture of decidual cells in vitro was successful ( Fig. 2A) . Then, these cells were transfected with miR-378a-3p mimics or inhibitors and their respective controls (40 nmol) for 24, 48 and 72 h to observe cell viability. MTT assay results showed that miR-378a-3p mimics increase decidual cell viability compared to the negative control (NC) (*P < 0.05) (Fig. 2B) . Furthermore, in decidual cells transfected with the miR-378a-3p inhibitors, viability is significantly decreased (P < 0.05). These results suggest that miR-378a-3p enhances decidual cell viability. In addition, after transfecting decidual cells with miR-378a-3p mimics or inhibitors for 48 h, apoptosis of these cells was analyzed by Annexin V-FITC/PI double-labeled flow cytometry. The apoptosis rate was defined as the sum of early apoptosis and late apoptosis. Our data show that over-expression of miR-378a-3p significantly reduces the apoptosis rate of decidual cells (28.56% ± 1.46 vs 39.33% ± 0.50; P < 0.05, Fig. 2B) . Furthermore, the apoptosis rate increases following . Data are presented as mean ± SEM, The significant difference between two groups was determined by Student's t-test *P < 0.05 and **P < 0.01. transfection with the inhibitors (54.01% ± 2.20 vs 35.17% ± 1.75; P < 0.05, Fig. 2B ). Taken together, these data indicate that miR-378a-3p may reduce apoptosis in decidual cells.
miR-378a-3p reduces Caspase-3 expression and activity
To analyze the underlying mechanisms of the anti-apoptosis function of miR-378a-3p, we investigated the activation of apoptosis-related signaling pathways. Western blot analysis showed no significant difference in the expression levels of Bcl-2, Bax, Bcl-X and ERK1/2 between miR-378a-3p over-expressing or miR-378a-3p inhibited cells. (Fig. 3A  and C) . However, Caspase-3 expression levels and activity were significantly reduced following transfection of miR-378a-3p mimics ( Fig. 3B and E) (P < 0.05). In contrast, transfection with the miR-378a-3p inhibitors led to a significant increase in Caspase-3 and CleavedCaspase-3 (Fig. 3D) . These results suggest that there may exist an interaction between miR-378a-3p and Caspase-3 in the decidual tissue which mediates apoptosis in decidual cells.
Caspase-3 is a target of the miR-378a-3p family
To explore the connection between miR-378a-3p and Caspase-3, we searched for potential targets of miR-378a-3p using bioinformatics analysis. One miR-378a-3p binding site was identified in the 3′-UTR of Caspase-3 (Fig. 4A) . To obtain direct evidence that Caspase-3 is the direct target of miR-378a-3p, we generated luciferase reporter constructs by cloning the 3′UTR of Caspase-3 into a pGL-3M-Luc vector. By co-transfection of the reporter plasmids and miR-378a-3p mimics in HEK-293 cells, we observed that miR-378a-3p mimics markedly inhibited the activity of Caspase-3-luciferase (Fig. 4B) . We Figure 3 MiR-378a-3p regulates Caspase-3 expression and activity. (A and B) Human decidual cells were cultured in vitro and transfected with NC or miR-378a-3p mimics (40 nM). After 24 h, cells were treated with serum starvation for another 2 days. The protein levels of BCL-2, ERK1/2, BAX, Caspase-3, Cleaved-Caspase-3 and β-Actin were assessed by performing a western blot analysis. (C and D) Decidual cells were transfected with inhibitor negative control (INC) or miR-378a-3p inhibitor (40 nM). After 24 h, cells were treated with serum starvation for another 2 days. The protein levels of BCL-2, ERK1/2, BAX, Caspase-3, Cleaved-Caspase-3 and β-actin were assessed by performing a western blot analysis. (E) Caspase-3 activity was measured in the lysates of cells transfected with NC, miR-378a-3p mimics, INC or miR-378a-3p inhibitor by colorimetric assay. One representative result of three independent experiments is shown (n = 3). Data represent the means ± SEM, protein expression is normalized to β-Actin expression. The significant difference between two groups was determined by Student's t-test *P < 0.05 and **P < 0.01. also found that miR-378c and miR-422a, the other two miRNAs of the miR-378a-3p family, could target Caspase-3 as well. Furthermore, as western blot showed that transfection with miR-378a-3p mimics also markedly decreased the protein level of Caspase-3 (Fig. 3B) . We investigated whether Caspase-3 protein level correlated with miR378a-3p expression in decidual tissues, expression of miR-378a-3p in decidua was measured by qRT-PCR and expression of Caspase-3 protein levels was measured by western blot. The results show a significant negative correlation between miR-378a-3p and Caspase-3 protein expression in decidual tissues (r = −0.4324, P = 0.0084; Fig. 4C ). In summary, Caspase-3 is a target of the miR-378a-3p family and endogenous Caspase-3 is directly regulated by miR-378a-3p in the human decidual cells.
Apoptosis and the expression of Caspase-3 is increased in the decidual tissue of EPL patients
To further confirm the mechanism by which miR-378a-3p regulates the function of decidua in the early pregnancy in vivo, the expression of Caspase-3 in the decidual tissues of EPL patients and normal pregnancies was measured by Q-PCR and western blot. Caspase-3 expression was induced significantly in the decidua of EPL both by measure of mRNA and protein level (P < 0.05, P < 0.01) (Fig. 5A and B) . In addition, we also investigated Caspase-3 expression and cell apoptosis in decidual tissues from EPL. Immunohistochemistry results suggest that TUNEL positive and Caspase-3 positive cells are likely to be increased in the EPL patients compared to that of the normal group (Fig. 5C) .
Progesterone regulates the expression of miR-378a-3p in decidual cells in vitro
Lastly, we compared the expression of miR-378a-3p in the decidua of normal, EPL and a progesterone-treated group. Interestingly, we found that miR-378a-3p expression was increased even more significantly in the progesterone-treated group compared to the EPL group (Fig. 6A) . Thus, in order to further explore the regulatory mechanism of miR378a-3p expression, we examined whether progesterone regulates its expression in human decidual cells in vitro. The concentrations of progesterone (10 −7 mol/l, 10 -6 mol/l) used were according to the physiological level and referenced by other articles (Jarvela et al., 2014; Piltonen et al., 2015) . We found that with an increase in concentration and duration of progesterone exposure, the expression of miR-378a-3p is increased (P < 0.05) (Fig. 6B, C) . These results suggest that progesterone may have a positive regulatory effect on miR-378a-3p.
Discussion
Accumulating evidence suggests that oxidative stress (OS) is a common pathophysiological feature in the different etiologies of EPL, independent of the presence or absence of a chromosomal abnormality (Jauniaux and Burton, 2005; Jauniaux et al., 2006) . Oxidative stress (OS) is known to trigger the caspase-cascade, leading to apoptosis in many other tissues (Burton et al., 2003) . Our previous studies have found that decidual cells in EPL are characterized by endoplasmic reticulum stress associated degradation (ERAD) and sustained endoplasmic reticulum (ER) stress signaling, followed by activation of Caspase-3 3′UTR mRNAs. (B) Cells were co-transfected with miRNA mimics, pRL-TK and the firefly luciferase reporter comprising the Caspase-3 3′-UTR. After 24 h, firefly luciferase activity was measured and normalized to Renilla luciferase activity. Data are presented as mean ± SEM. The significant difference between two groups was determined by Student's t-test. *P < 0.05 and **P < 0.01. (C) the correlation between miR-378a-3p and Caspase-3 were analyzed using Spearman correlation test. Relative expression of miR-378a-3p in decidua was determined by qRT-PCR and normalized to the expression of U6. Differential expression of Caspase-3 in protein levels was determined by western blotting. ( • : normal pregnant women, n = 18; ο : EPL patients n = 16). *P < 0.05, significant correlation by Spearman correlation test.
apoptosis via over-expression of Caspase-4 and Caspase-12 (Liu et al., 2011) . In this study, the factors related to the regulation of the apoptosis of the decidual cells were studied at the level of posttranscriptional regulation. Our results show that down-regulation of miR-378a-3p in the decidua of EPL is associated with increased apoptosis by over-expressed Caspase-3. MiR-378a-3p has been found to be associated with many other diseases. Studies have demonstrated that miR-378a-3p plays an integral regulating role in the occurrence, development, metastasis and cell apoptosis of tumors such as non-small cell lung cancer, stomach and colon cancer (Zhang et al., 2007; Feng et al., 2011; Chen et al., 2012; Wu et al., 2012; Li et al., 2014) . Previous studies have also demonstrated that miR-378a-3p is highly expressed in skeletal muscle, promoting differentiation, and repressing the proliferation of C2C12 myoblast cells by targeting Histone Deacetylase 4 (HDAC4) (Wei et al., 2016) . However, no reports have yet explored the relationship between miR-378a-3p and EPL. In the present study, miRNA array analysis identified seven differentially expressed miRNAs in the decidual tissues of EPL whose expression levels varied more than 1.5-fold relative to levels in decidual tissues of the control group. Using MTT assay and flow cytometry, we determined that miR-378a-3p increases the viability and decreases the apoptosis in decidual cells. These results suggest that miR-378a-3p may be involved in the development of EPL through its influence on decidual cell viability and apoptosis. To the best of our knowledge, this is the first time the relationship between miR-378a-3p and early pregnancy has been established. However, the effect of miR-378a-3p on decidual cells is unlike that previously reported on myoblasts cells (Wei et al., 2016) .
Our previous studies have already identified morphological features suggesting an increase in apoptosis in the decidua of EPL (Liu et al., 2011) . A member of the cysteine protease family, caspase activity manifests itself from the early stages of embryogenesis to organism death (Dubova et al., 2014) . There are three subgroups of mammalian caspases, which are classified according to domain structure, characteristics of the substrate cleavage, and function (Fiandalo and Kyprianou, 2012) . Caspase-3 belongs to the second group, which regulates apoptosis. Caspase8/10 can activate Caspase-3, which then reacts with numerous other proteins eventually leading to programmed cell death (Olsson and Zhivotovsky, 2011) . Fang et al. (2012) using bioinformatics algorithms such as TargetScan, MiRanda and Pictar, reported for the first time that Figure 5 Apoptosis and the expression of Caspase-3 is increased in the decidual tissue from EPL patients. (A) The mRNA level of Caspase-3 in the decidual tissues from EPL patients (n = 10) and normal (n = 10) was determined by qRT-PCR and normalized to the expression of GAPDH. The significant difference between two groups was determined by Mann-Whitney U-test. (B) Differential expression of Caspase-3 in protein levels was determined by western blot. The significant difference between two groups was determined by Student's t-test. (C) Immunohistochemistry of Caspase-3 and TUNEL indecidual tissue sections derived from EPL patients and normal was analyzed by fluorescence microscopy (magnification, 40×). Data are presented as mean ± SEM, *P < 0.05 and **P < 0.01. Scale bars, 50 μm.
Caspase-3, an important executor of apoptosis, was the target of miR378a-3p. In our study, we also found direct evidence that Caspase-3 is a target of the miR-378a-3p family. Moreover, the expression of miR378a-3p and Caspase-3 is significantly negatively correlated in decidual tissues. These results suggest that miR-378a-3p regulation of Caspase-3 may be associated with EPL. Given that the expression of miR-378c and miR-422a, the other two miRNAs of the miR-378a-3p family are also decreased in the EPL decidua, we speculate that they might also co-operatively regulate Caspase-3 expression and the apoptosis of decidual cells. In addition, we found that the expression levels of miR378a-3p is significantly lower in the plasma from the EPL group compared to that of the control group, suggesting that miR-378a-3p could potentially be a predictive marker for EPL. We also found a strong negative correlation between miR-378a-3p and Caspase-3 expression in decidual tissue, suggesting that this regulatory relationship likely reflects biological mechanisms in the decidua that may, when dysregulated, influence EPL. However, we have not excluded the fact that the differences in miR-378a-3p and Caspase-3 expression in decidual tissue could be a consequence of EPL. The exact regulatory mechanism will need to be confirmed with more experimental evidence.
An unexpected discovery from our study is that progesterone could upregulate the expression of miR-378a-3p in decidual cells, which to the best of our knowledge has never previously been reported. In RT-qPCR studies of the decidual tissues of the three groups (normal group, EPL group and progesterone-treated group), we observed that miR-378a-3p expression is reduced in the EPL group compared to the control group. Furthermore, the expression of miR-378a-3p in the progesteronetreated group is higher than that in the EPL group. In the later experiment in vitro, we found that with increased progesterone concentration and with prolonged exposure, the expression of miR-378a-3p is significantly increased. From this result, we speculate that progesterone may have a role to play in the treatment and rescue of EPL through inducing the expression of miR-378a-3p. Despite this interesting discovery, key steps surrounding this specific mechanism are still unclear, and should be explored with further research.
In conclusion, down-regulation of miR-378a-3p is associated with increased apoptosis through increased expression of Caspase-3 in deciduas of EPL, which may be a potential underlying mechanism of EPL. Our demonstration that progesterone up-regulates the expression of miR-378a-3p suggests a new mechanism of progesteronetreatment for EPL. Further studies on other differentially expressed miRNAs and the mechanisms of miRNA regulation may provide more useful information about the pathogenesis of EPL.
